Author(s):
Mahima Trivedi, Shruti Rathore, M.K. Gupta
Email(s):
drshrutirathore@gmail.com
DOI:
10.52711/0974-360X.2026.00694 
Address:
Mahima Trivedi1, Shruti Rathore2, M.K. Gupta3
1School of Pharmacy, Career Point University, Kota (Rajasthan),
2Chouksey College of Pharmacy, Bilaspur, Chhattisgarh, India 495001,
3School of Pharmacy, Career Point University, Kota (Rajasthan), India 325003
*Corresponding Author
Published In:
Volume - 19,
Issue - 10,
Year - 2026
ABSTRACT:
Nanocarrier-based transdermal drug delivery systems (TDDS) represent a cutting-edge approach to overcoming the limitations of traditional TDDS. This comprehensive review delves into the mechanisms, types, advantages, challenges, and future prospects of nanocarrier-based TDDS, highlighting their key benefits, including enhanced drug permeability, controlled release, reduced side effects, and improved stability and bioavailability. The review explores a range of nanocarriers, each with unique properties that enhance their efficacy in TDDS. Clinical applications, such as pain management, hormone replacement therapy, and cancer treatment, are also discussed. To address limitations like poor skin permeability and rapid drug degradation, nanoparticles containing TDDS have been developed, showing improved skin permeation, stability, and bioavailability. This review underscores the promising future of nanocarrier-based TDDS, with ongoing research focused on innovative approaches like smart nanocarriers, personalized medicine, and advanced characterization techniques, ultimately aiming to improve patient outcomes and expand therapeutic possibilities.
Cite this article:
Mahima Trivedi, Shruti Rathore, M.K. Gupta. Nanoparticles Containing Transdermal Drug Delivery Systems: A Novel Approach for Enhanced Therapeutic Efficacy. Research Journal Pharmacy and Technology. 2026;19(10):4987-4. doi: 10.52711/0974-360X.2026.00694
Cite(Electronic):
Mahima Trivedi, Shruti Rathore, M.K. Gupta. Nanoparticles Containing Transdermal Drug Delivery Systems: A Novel Approach for Enhanced Therapeutic Efficacy. Research Journal Pharmacy and Technology. 2026;19(10):4987-4. doi: 10.52711/0974-360X.2026.00694 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2026-19-10-71
REFERENCES:
1. Kumari P, Pathak K, Yadav J. Recent advancements in transdermal drug delivery systems: A review. Biomater Res. 2022; 26(1): 1–20.
2. Kumar A, Kumar A. Innovations in transdermal drug delivery systems: A comprehensive review. Indian J Pharm Sci. 2022; 84(1): 5–14.
3. Rao R, Naidu R. Overcoming challenges in transdermal drug delivery. J Adv Pharm Technol Res. 2023; 14(1): 45–55.
4. Kango S, Kalia S, Celli A, Njuguna J, Habibi Y, Kumar R. Surface modification of inorganic nanoparticles for development of organic–inorganic nanocomposites: A review. Prog Polym Sci. 2013; 38(8): 1232–1261.
5. Kumar P, Chhibber S, Mahajan R. Nanotechnology-based approaches for transdermal drug delivery: A comprehensive review. J Drug Deliv Sci Technol. 2023; 67: 102932.
6. Sharma A, Garg T. Recent advancements in nanotechnology-based transdermal drug delivery systems. Expert Opin Drug Deliv. 2024; 21(3): 297–312.
7. Zeb A, Malik M, Shah F. Potential of nanoparticulate carriers for improved drug delivery via skin. J Pharm Investig. 2018; 49: 485–517.
8. Gupta R, Sharma P. Recent developments in liposomal drug delivery systems for transdermal applications. Int J Pharm.2024;617:121639.
9. Singh A, Kaur H. Recent advances in niosomal drug delivery systems for transdermal applications. Asian J Pharm Sci. 2022;17(3):456–470.
10. Kumar P, Gupta R. Solid lipid nanoparticles: An efficient nanocarrier for transdermal drug delivery. Indian J Pharm Sci. 2022; 84(3): 221–232.
11. Patil A, Deshmukh T. Nanostructured lipid carriers: A novel approach for transdermal drug delivery. Indian J Pharm Sci. 2022; 84(4): 332–345.
12. Kumar S, Gupta N. Polymeric nanoparticles for transdermal drug delivery: Design, characterization, and applications. J Pharm Biomed Anal. 2024; 233: 115304.
13. Patel M, Shah R. Dendrimers: Promising nanocarriers for transdermal drug delivery. Indian J Pharm Sci. 2022; 84(6): 567–582.
14. Reddy A, Gupta V. Hydrogels for transdermal drug delivery: Recent advancements and future prospects. Indian J Pharm Sci. 2022; 84(7): 634–649.
15. Patel D, Gupta R. Enhancing transdermal drug delivery with nanocarriers: A comprehensive review. Indian J Pharm Sci. 2022; 84(5): 456–472.
16. Kumar A, Verma S. Nanocarrier-mediated transdermal drug delivery: Mechanisms and clinical applications. J Pharm Biomed Anal. 2024; 234: 115308.
17. Patel R, Desai A. Skin irritation and toxicity concerns in nanocarrier-based transdermal drug delivery systems. J Pharm Sci. 2022; 110(4): 1523–1531.
18. Sinha P, Joshi R. Challenges in the manufacturing of nanocarriers for transdermal drug delivery. Int J Pharm. 2023; 607: 120979.
19. Sharma R, Mehta P. Innovations in manufacturing processes for nanocarrier-based drug delivery. J Pharm Innov. 2023; 18(1): 78–87.
20. Sharma P, Singh J. Liposomal lidocaine for enhanced pain management: A review. Indian J Pain. 2021; 35(2): 120–127.
21. Verma S, Gupta R. Niosome-based transdermal delivery of estradiol: Formulation and clinical outcomes. J Pharm Sci. 2023; 112(4): 983–992.
22. Kaur P, Malhotra S. Liposomal tacrolimus in atopic dermatitis: Clinical efficacy and safety. Indian J Dermatol VenereolLeprol. 2021; 87(6): 765–772.
23. Roy S, Banerjee A. Transdermal delivery of 5-fluorouracil using polymeric nanoparticles: A clinical perspective. Cancer Nanotechnol. 2022; 13(1): 45–55.
24. Singh N, Kapoor G. Polymeric nanoparticles for transdermal delivery of influenza vaccines: Current status and future perspectives. J Immunol Res. 2022; 2022: 1–11.
25. Garg B, Jain A, Singh S. Smart nanocarriers: A promising approach for transdermal drug delivery systems. Int J Nanomedicine. 2023; 18: 325–340.
26. Rathor S, Ram A. Formulation and characterization of an intragastric floating drug delivery system of doxorubicin hydrochloride: in vitro-in vivo release study. Asian J of Pharmaceutical and Clinical Research. 2012 Mar 1; 5: 150-8.
27. Rathor SH, Ram AL. Floating drug delivery system as an approach to increase the gastric retention of methotrexate: formulation and evaluation. Asian Journal of Pharmaceutical and Clinical Research. 2013; 6(1): 42-7.
28. Rathor S, Ram A. Formulation and characterization of an intragastric floating drug delivery system of doxorubicin hydrochloride: in vitro-in vivo release study. Asian J of Pharmaceutical and Clinical Research. 2012 Mar 1; 5: 150-8.
29. Rathor S, Ram A. Porous microsphere of 5flouru uracil: a tool for site specific drug delivery in gastric cancer. Int. J. Curr. Pharm. Res. 2011; 3(1): 38-42.
30. Dipesh L, Pranay S, Shruti R. Formulation and evaluation of new medicated chewing gum for the treatment of nausea and vomiting induced by chemotherapy, radiation therapy and post operative conditions in cancer. Asian Journal of Pharmaceutical and Clinical Research. 2020; 13(4): 157-60.
31. Rathore S, Ram A, Lall D, Agrawal B, Soni P, Naim MJ. Development and evaluation of sunscreen cream containing benzophenone-3 microspheres for enhancing sunscreen activity. Research Journal of Pharmacy and Technology. 2021 Nov 1; 14(11): 6078-84.
32. Sandey L, Rathore S, Shambhakar S, Roy A. Development and Characterization of Modafinil Loaded Mucoadhesive Niosomes: A Targeted Drug Delivery to Brain. Research Journal of Pharmacy and Technology. 2024 May 1; 17(5): 2365-71.
33. Lall D, Rathore S. Development and Evaluation of Biodegradable Microneedle Patches for Sustained Release of Ondansetron: A Novel Approach to Chemotherapy-Induced Nausea Management". Frontiers in Health Informatics. 2024 Apr 1; 13(3).
34. Trivedi M, Rathore S. Formulation, Development and In-vitro Characterization of Doxorubicin loaded Solid Lipid Nanoparticles for the effective management of Lung Cancer Topic. Research Journal of Pharmacy and Technology. 2025; Dec 1; 18(12): 5718-22.